Citation Impact
Citing Papers
Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction
2020 Standout
Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach
2023 StandoutNobel
Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.
1997
Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats
1996
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
Pathophysiology of Progressive Nephropathies
1998 Standout
Effect of Gender on the Progression of Nondiabetic Renal Disease
2000
Management of idiopathic membranous nephropathy: Evidence-based recommendations
1999
Dissection of Key Events in Tubular Epithelial to Myofibroblast Transition and Its Implications in Renal Interstitial Fibrosis
2001 Standout
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
2016 Standout
Epidemiology of chronic kidney disease: an update 2022
2022 Standout
Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy
2009 Standout
Anti-Neutrophil Cytoplasmic Autoantibodies with Specificity for Myeloperoxidase in Patients with Systemic Vasculitis and Idiopathic Necrotizing and Crescentic Glomerulonephritis
1988 Standout
Preeclampsia: Novel Mechanisms and Potential Therapeutic Approaches
2018
Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis
1991
Collagen studies in newborn rat kidneys with incomplete ureteric obstruction
1993
Phenotype 2 Familial Mediterranean Fever: Evaluation of 22 Case Series and Review of the Literature on Phenotype 2 FMF
2012
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
The Pathogenesis of Chronic Renal Failure in Diabetic Nephropathy
1991
β-Edge Interactions in a Pentadecameric Human Antibody Vκ Domain
2006 StandoutNobel
Pre-eclampsia
2000
Pathologic Classification of Diabetic Nephropathy
2010 Standout
Guideline of transthyretin-related hereditary amyloidosis for clinicians
2013 Standout
[2] Isolation and characterization of amyloid fibrils from tissue
1999
The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway
2005 Standout
A More Accurate Approach to Amyloid Detection and Subtyping: Combining in situ Congo Red Staining and Immunohistochemistry
2016
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis
1994
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Importance of quantitative genetic variations in the etiology of hypertension
2000 StandoutNobel
Transforming Growth Factor β in Tissue Fibrosis
1994 Standout
Understanding the nature of renal disease progression
1997
Amyloid neuropathy: a retrospective study of 35 peripheral nerve biopsies
2004
Rituximab for idiopathic membranous nephropathy
2002
The impact of gender on the progression of chronic renal disease
1995
The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies
2004
Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy
2000 StandoutNobel
Molecular Mechanisms of Amyloidosis
2003 Standout
Circulating Angiogenic Factors and the Risk of Preeclampsia
2004 Standout
Misdiagnosis of Hereditary Amyloidosis as AL (Primary) Amyloidosis
2002
Cell Biology of the Glomerular Podocyte
2003 Standout
Protein Misfolding, Functional Amyloid, and Human Disease
2006 Standout
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Imaging linear birefringence and dichroism in cerebral amyloid pathologies
2003
Tubulointerstitial Changes as a Major Determinant in the Progression of Renal Damage
1992 Standout
Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain.
1993
Chronic Renal Diseases: Renoprotective Benefits of Renin–Angiotensin System Inhibition
2002
Interstitial myofibroblasts: predictors of progression in membranous nephropathy.
1997
Pathways to nephron loss starting from glomerular diseases—Insights from animal models
2005
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
Pathologic differentiation between lupus and nonlupus membranous glomerulopathy
1983
The Association Between Idiopathic Hemolytic Uremic Syndrome and Infection by Verotoxin-Producing Escherichia coli
1985 Standout
Hemolytic-Uremic Syndrome: Current Concepts and Management
1982
Works of H.-V. Gärtner being referenced
High-sensitivity diagnosis of AA amyloidosis using Congo red and immunohistochemistry detects missed amyloid deposits.
1995
Preeclamptic nephropathy – an endothelial lesion
1998
Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes.
1989
Comparison of Clinical and Morphological Features of Peri- (Epi-Extra) Membranous Glomerulonephritis
1974
Malignant Nephrosclerosis in Patients with Hemolytic Uremic Syndrome (Primary Malignant Nephrosclerosis)
1977